| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/10/1995 | EP0651646A1 Therapeutic conjugates of toxins and drugs |
| 05/10/1995 | EP0651609A1 Pasteurella multocida toxoid vaccines |
| 05/10/1995 | EP0507831B1 Method to detect bone and other connective tissue disorders in humans and animals |
| 05/10/1995 | EP0496835B1 Solid tumor treatment method and composition |
| 05/10/1995 | EP0491824B1 Human parvovirus b19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| 05/10/1995 | EP0477231B1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 05/10/1995 | EP0366718B1 Monoclonal antibodies neutralizing hiv-1 |
| 05/10/1995 | EP0222842B1 Cloning and expression of host-protective immunogens of ibdv |
| 05/09/1995 | US5414085 Barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
| 05/09/1995 | US5413931 Ehrlichia species from a patient suffering from ehrlichiosis |
| 05/09/1995 | US5413927 Feline immunodeficiency virus isolate NCSU1Lb |
| 05/09/1995 | US5413914 Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| 05/09/1995 | US5413912 Peptide for detecting antibodies to a 260 kD T. cruzi antigen |
| 05/09/1995 | US5413910 Measuring non-dystrophin proteins and diagnosing muscular dystrophy |
| 05/04/1995 | WO1995011998A1 Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics |
| 05/04/1995 | WO1995011977A2 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA) |
| 05/04/1995 | WO1995011975A2 Retroviral superantigens, superantigen peptides, and methods of use |
| 05/04/1995 | WO1995011919A2 RECOMBINANT PilC PROTEINS, PROCESS FOR PRODUCING THEM AND THEIR USE |
| 05/04/1995 | WO1995011912A2 Biopolymer synthesis utilizing surface activated, organic polymers |
| 05/04/1995 | WO1995011704A1 Liposome having oligosaccharide on the surface |
| 05/04/1995 | WO1995011702A1 Prokaryotic expression of mhc proteins |
| 05/04/1995 | WO1995011701A1 Inhibition of hiv mucosal infection |
| 05/04/1995 | WO1995011700A1 Submicron emulsions as vaccine adjuvants |
| 05/04/1995 | WO1995011699A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 05/04/1995 | WO1995006728A3 T cell epitopes of ryegrass pollen allergen |
| 05/04/1995 | WO1994028132A3 Opioid receptors: compositions and methods |
| 05/04/1995 | DE4432338A1 Impfstoff zur Verhinderung des reproduktiven und respiratorischen Syndroms bei Schweinen Vaccine for the prevention of reproductive and respiratory syndrome in pigs |
| 05/04/1995 | CA2467757A1 B1k chain of laminin and methods of use |
| 05/04/1995 | CA2175579A1 Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics |
| 05/04/1995 | CA2175255A1 Retroviral superantigens, superantigen peptides, and methods of use |
| 05/04/1995 | CA2175089A1 Prokaryotic expression of mhc proteins |
| 05/04/1995 | CA2174943A1 A new ribosome-inactivating protein isolated from the plant bryonia dioica |
| 05/04/1995 | CA2169453A1 Inhibition of hiv mucosal infection |
| 05/03/1995 | EP0650734A1 Polyvalent live varal vaccine |
| 05/03/1995 | EP0650733A1 Live in ovo vaccine |
| 05/03/1995 | EP0650722A2 Invasive particles with protein coating |
| 05/03/1995 | EP0650596A1 Compositions and methods for regulating cellular signal transducing systems |
| 05/03/1995 | EP0650527A1 IMPROVEMENT IN $i(BORRELIA BURGDORFERI) DIAGNOSIS AND PROPHYLAXIS |
| 05/03/1995 | EP0650522A1 Novel cyclophilins, associating proteins and uses |
| 05/03/1995 | EP0650498A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein |
| 05/03/1995 | EP0650371A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 05/03/1995 | EP0650369A1 Major histocompatibility complex antigens for use as vaccine against an immunodeficiency virus |
| 05/03/1995 | EP0504202B1 Improved meningococcal polysaccharide conjugate vaccine |
| 05/03/1995 | EP0456724B1 Composition and method for treating benign prostatic hypertrophy |
| 05/03/1995 | EP0407544B1 Monoclonal antibody against protein c |
| 05/03/1995 | EP0406398B1 Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
| 05/03/1995 | EP0345318B1 Human gamma, delta t cell antigen receptor polypeptides and nucleic acids |
| 05/02/1995 | US5412077 Screening blood |
| 05/02/1995 | US5412073 Polypeptides and DNA coding therefor |
| 05/02/1995 | US5411884 Monoclonal antibody L53 which recognizes a human tumor-associated antigen |
| 05/02/1995 | US5411882 Cytokine which mediates inflammation |
| 05/02/1995 | US5411749 Human lymphoid tissue in an immunocompromised host |
| 05/02/1995 | US5411732 Preparing vaccines |
| 05/02/1995 | CA1335429C Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor |
| 04/28/1995 | CA2109337A1 Polypeptides and polynucleotides related to the pa-i lectin of pseudomonas aeruginosa |
| 04/27/1995 | WO1995011317A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/27/1995 | WO1995011314A1 Detection of alzheimer's disease and other diseases using an improved photoaffinity labeling method |
| 04/27/1995 | WO1995011311A1 METHOD OF BINDING MATERIAL TO THE β-AMYLOID PEPTIDE |
| 04/27/1995 | WO1995011309A2 A novel nuclear mitotic phosphoprotein: mitosin |
| 04/27/1995 | WO1995011307A1 Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis |
| 04/27/1995 | WO1995011259A1 Platelet-derived growth factor analogues |
| 04/27/1995 | WO1995011256A1 Conotoxin peptides |
| 04/27/1995 | WO1995011255A1 Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide |
| 04/27/1995 | WO1995011040A1 The cloning of duffy blood group antigen |
| 04/27/1995 | WO1995011010A1 Methods and compositions for microencapsulation of antigens for use as vaccines |
| 04/27/1995 | WO1995011009A1 Method for preparing microspheres comprising a fluidized bed drying step |
| 04/27/1995 | WO1995011008A2 Methods and compositions for microencapsulation of adjuvants |
| 04/27/1995 | WO1995007101A3 Living salmonella vaccine |
| 04/27/1995 | WO1995006726A3 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis |
| 04/27/1995 | CA2174532A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/27/1995 | CA2174501A1 Method of binding material to the .beta.-amyloid peptide |
| 04/27/1995 | CA2173993A1 Detection of alzheimer's disease and other diseases using an improved photoaffinity labeling method |
| 04/27/1995 | CA2173978A1 A novel nuclear mitotic phosphoprotein: mitosin |
| 04/27/1995 | CA2173206A1 The cloning of duffy blood group antigen |
| 04/27/1995 | CA2173138A1 Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide |
| 04/26/1995 | EP0649906A1 Nucleotide sequences coding for a protein with urease activity |
| 04/26/1995 | EP0649537A1 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes |
| 04/26/1995 | EP0649475A1 PEPTIDE FOR DIAGNOSING AND IMMUNIZING AGAINST $i(T. cruzi) INFECTION |
| 04/26/1995 | EP0649470A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 04/26/1995 | EP0649435A1 Membrane-associated immunogens of mycobacteria |
| 04/26/1995 | EP0649433A1 Antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them |
| 04/26/1995 | EP0544746B1 Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 04/26/1995 | EP0482076B1 Stable vaccine compositions containing interleukins |
| 04/26/1995 | EP0419513B1 Recombinant flagellin vaccines |
| 04/26/1995 | EP0381706B1 A method of maintaining a desired recombinant gene in a genetic population of cells |
| 04/26/1995 | CN1101941A Method for suspending, adsorbing and multiplicating virus of hepatitis A |
| 04/25/1995 | US5410025 Passing polyclonal material through anion exchange column to absorb immunoglobulins, eluting low anticomplementary fraction with sodium chloride gradient and buffer under acidic conditions |
| 04/25/1995 | US5409990 Useful for replacement therapy in patient suffering from hemophilia B |
| 04/25/1995 | US5409901 Treating arteriosclerosis by administering an animal extracted nucleoproteins |
| 04/25/1995 | US5409698 Liposome immunoadjuvants containing IL-2 |
| 04/25/1995 | CA1335405C Oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines |
| 04/25/1995 | CA1335347C Methods and compositions for the treatment of non-ige-mediated diseases |
| 04/20/1995 | WO1995010777A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | WO1995010632A1 Anti-paramyxovirus screening method and vaccine |
| 04/20/1995 | WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | WO1995010540A1 Fas antagonists and uses thereof |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010536A1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 04/20/1995 | WO1995010302A1 Cellular and serum protein anchors and conjugates |
| 04/20/1995 | WO1995010301A1 Immunological tolerance-inducing agent |